首页> 外文期刊>Indian Journal of Chemistry, Section B. Organic Including Medicinal >Experimental and computational evaluation of new quinolinyl chalcones as potent antiplasmodial agents
【24h】

Experimental and computational evaluation of new quinolinyl chalcones as potent antiplasmodial agents

机译:新型喹啉基查耳酮作为有效抗疟原虫药物的实验和计算评估

获取原文
获取原文并翻译 | 示例
           

摘要

In a search for new antiplasmodial agents, a series of thirty five diversely substituted chalcones derived from a quinoline-chalcone scaffold e.g. (E)-3-(2-chloroquinolin-3-yl)-1-(2-hydroxyphenyl) prop-2-en-1-one / (E)-(2-chloro-6-ethoxyquinolin-3-yl) (2-hydroxyphenyl) prop-2-en-1-one and (22)-3-(2-chloroquinolin-3-yl)-1-(2-hydroxyphenyl)-3-iodoprop-2-en-1-one are synthesized and studied. Compounds are prepared via Claisen-Schmidt condensations of 2-chloro-3-formyl quinoline / 2-chloro-6-ethoxy-3-formyl quinoline with appropriately substituted 2-hydroxy acetophenones. All compounds are assayed for their binding in the active sites of Plasmodium falciparum lactate dehydrogenase (pfLDH) enzyme. The quinoline chalcone derivatives showed negative binding energies promising potent pfLDH inhibitory activity. Compounds showing the highest negative binding scores have been studied for their in vitro antimalarial activity against cultured Plasmodium falciparum 3D7 strain. The compounds 2c and 2u have completely inhibited the maturation of parasites at MIC 10 μg/mL and above whereas 3b inhibited 95% maturation of parasites at MIC 50 μg/mL. Additional efforts are being directed towards elaborating these leads towards the discovery and development of new quinolinyl heterocycles as anti-malarial agents.
机译:为了寻找新的抗疟原虫剂,衍生自喹啉-查耳酮骨架例如丙烯酰胺的35个系列的不同取代的查耳酮。 (E)-3-(2-氯喹啉-3-基)-1-(2-羟基苯基)丙-2-烯-1-酮/(E)-(2-氯-6-乙氧基喹啉-3-基) (2-羟苯基)丙-2-烯-1-酮和(22)-3-(2-氯喹啉-3-基)-1-(2-羟苯基)-3-碘丙-2-烯-1-酮被合成和研究。通过2-氯-3-甲酰基喹啉/ 2-氯-6-乙氧基-3-甲酰基喹啉与适当取代的2-羟基苯乙酮的克莱森-施密特缩合制备化合物。测定所有化合物在恶性疟原虫乳酸脱氢酶(pfLDH)酶的活性位点的结合。喹啉查尔酮衍生物表现出负的结合能,有力地抑制了pfLDH的活性。已经研究了显示最高负结合得分的化合物针对体外培养的恶性疟原虫3D7菌株的抗疟活性。化合物2c和2u完全抑制了MIC为10μg/ mL及以上的寄生虫的成熟,而化合物3b抑制了MIC为50μg/ mL的寄生虫的95%的成熟。目前正致力于其他方面的努力,以阐明这些线索,以发现和开发新的喹啉基杂环化合物作为抗疟剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号